Geode Capital Management’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History
Bought
Maintained
Sold
Geode Capital Management's OCAT Position: Q1 2016 in Review
Geode Capital Management sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 241,991 shares — an estimated $2.04M sold.
Geode Capital Management first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $2.04M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.
- Geode Capital Management reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
- Geode Capital Management sold 241,991 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $2.04M.
- Geode Capital Management first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
- Geode Capital Management's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $2.04M in Q4 2015.
- 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.
Based on Geode Capital Management's 13F filing for Q1 2016, filed 13 May 2016.